A Probable Case of Clarithromycin-Digoxin
... inhibited by clarithromycin, while cellular accumulation of digoxin increased on both sides of the cell.18 In addition, gastrointestinal flora metabolize digoxin into digoxin-related products (DRPs), which are less cardioactive than digoxin.1,2,20 Eubacterium lentum, an anaerobic bacillus, is respon ...
... inhibited by clarithromycin, while cellular accumulation of digoxin increased on both sides of the cell.18 In addition, gastrointestinal flora metabolize digoxin into digoxin-related products (DRPs), which are less cardioactive than digoxin.1,2,20 Eubacterium lentum, an anaerobic bacillus, is respon ...
attenuation of hemodynamic response to extubation with injection
... response to tracheal extubation, which persist into the recovery period.3 Bidwai et al8 and Dyson et al15 demonstrated increases of 20% or more in these hemodynamic variables following extubation in normotensive patients. Lignocaine attenuates the hemodynamic response to tracheal extubation by its d ...
... response to tracheal extubation, which persist into the recovery period.3 Bidwai et al8 and Dyson et al15 demonstrated increases of 20% or more in these hemodynamic variables following extubation in normotensive patients. Lignocaine attenuates the hemodynamic response to tracheal extubation by its d ...
HIGHLIGHTS OF PRESCRIBING INFORMATION
... NEXIUM® is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. For those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of NEXIUM may be considered. Maintenanc ...
... NEXIUM® is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. For those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of NEXIUM may be considered. Maintenanc ...
Nanoparticles as `smart` pharmaceutical delivery
... commercially available and ongoing clinical trials have been provided. ...
... commercially available and ongoing clinical trials have been provided. ...
Notice to Applicants
... Reformatting of dossiers of already authorised products: There is no obligation to reformat the dossier of already authorised medicinal products into the new EU-CTD format. If a marketing authorisation holder (MAH) wishes to reformat the documentation, such reformatting will be allowed, although it ...
... Reformatting of dossiers of already authorised products: There is no obligation to reformat the dossier of already authorised medicinal products into the new EU-CTD format. If a marketing authorisation holder (MAH) wishes to reformat the documentation, such reformatting will be allowed, although it ...
Notice to Applicants, Volume 2B - European Commission
... Reformatting of dossiers of already authorised products: There is no obligation to reformat the dossier of already authorised medicinal products into the new EU-CTD format. If a marketing authorisation holder (MAH) wishes to reformat the documentation, such reformatting will be allowed, although it ...
... Reformatting of dossiers of already authorised products: There is no obligation to reformat the dossier of already authorised medicinal products into the new EU-CTD format. If a marketing authorisation holder (MAH) wishes to reformat the documentation, such reformatting will be allowed, although it ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
... hemodynamic response could contribute to the IOP lowering effect [13]. In the present study, HR and MAP increased significantly after intubation in the control group. On the contrary, in patients who received dexmedetomidine pre- medication, this response was attenuated. Several previous studies hav ...
... hemodynamic response could contribute to the IOP lowering effect [13]. In the present study, HR and MAP increased significantly after intubation in the control group. On the contrary, in patients who received dexmedetomidine pre- medication, this response was attenuated. Several previous studies hav ...
PRODUCT MONOGRAPH Cipralex Escitalopram Oxalate
... When discontinuing treatment, patients should be monitored for symptoms that may be associated with discontinuation (e.g. dizziness, abnormal dreams, sensory disturbances [including paraesthesias and electric shock sensations], agitation, anxiety, emotional indifference, impaired concentration, head ...
... When discontinuing treatment, patients should be monitored for symptoms that may be associated with discontinuation (e.g. dizziness, abnormal dreams, sensory disturbances [including paraesthesias and electric shock sensations], agitation, anxiety, emotional indifference, impaired concentration, head ...
Reconstitution and dosing for subcutaneous and IV administration
... for subcutaneous administration is different from the volume for IV administration. Use caution when calculating the volume to be administered ▼ The reconstituted concentration for subcutaneous administration is greater than the reconstituted concentration for IV administration – For subcutaneous re ...
... for subcutaneous administration is different from the volume for IV administration. Use caution when calculating the volume to be administered ▼ The reconstituted concentration for subcutaneous administration is greater than the reconstituted concentration for IV administration – For subcutaneous re ...
Oral terbinafine and erectile dysfunction
... information became available. For the latest information, including the official SmPC’s, please refer to website of the MEB www.cbg‐meb.nl ...
... information became available. For the latest information, including the official SmPC’s, please refer to website of the MEB www.cbg‐meb.nl ...
hollyhanzel
... and population size can be controlled with animals. However, with clinical trials, humans drop out of studies for various reasons, do not obey one hundred percent with the timing and compliance of doses, and have varying diets and exercise routines. Another reason is that researchers can perform exp ...
... and population size can be controlled with animals. However, with clinical trials, humans drop out of studies for various reasons, do not obey one hundred percent with the timing and compliance of doses, and have varying diets and exercise routines. Another reason is that researchers can perform exp ...
Astragalus membranaceus Monograph
... The polysaccharide fraction F3 potentiated the lymphokine-activated killer (LAK) cellinducing activity of IL-2 in cancer and AIDS patients.18 To investigate the immune regulation of the flavonoids of Astragalus membranaceus, monoclonal antibody assays of changes in total T-cell count and subsets wer ...
... The polysaccharide fraction F3 potentiated the lymphokine-activated killer (LAK) cellinducing activity of IL-2 in cancer and AIDS patients.18 To investigate the immune regulation of the flavonoids of Astragalus membranaceus, monoclonal antibody assays of changes in total T-cell count and subsets wer ...
Critical Management of Status Epilepticus
... useful when the clinical examination is limited. cEEG is used to guide management of pharmacological coma for treatment of increased intracranial pressure. An emerging application for cEEG is to detect new or worsening brain ischemia in patients at high risk, especially those with subarachnoid hemor ...
... useful when the clinical examination is limited. cEEG is used to guide management of pharmacological coma for treatment of increased intracranial pressure. An emerging application for cEEG is to detect new or worsening brain ischemia in patients at high risk, especially those with subarachnoid hemor ...
GHB - CAP Members
... Methods of abuse GHB and its analogues are abused for their euphoric and calming effects and because some people believe they build muscles and cause weight loss. GHB and its analogues are also misused for their ability to increase libido, suggestibility, passivity, and to cause amnesia (no memory o ...
... Methods of abuse GHB and its analogues are abused for their euphoric and calming effects and because some people believe they build muscles and cause weight loss. GHB and its analogues are also misused for their ability to increase libido, suggestibility, passivity, and to cause amnesia (no memory o ...
Guideline for the Management of Postoperative Nausea and Vomiting
... related to length of hospital stay. Cost of medications to prevent and treat PONV must be weighed against improved surgical experience for the patient and decreased costs to the system. Values: Recommendations were made according to the guidelines developed by the Canadian Task Force on Preventive H ...
... related to length of hospital stay. Cost of medications to prevent and treat PONV must be weighed against improved surgical experience for the patient and decreased costs to the system. Values: Recommendations were made according to the guidelines developed by the Canadian Task Force on Preventive H ...
2013 Pharmacist Liability
... Over the 10-year period included in the study, there were 1,409 reported medication-related incidents, adverse patient outcomes and actual claims against pharmacists, pharmacy technicians, other pharmacy personnel and pharmacy entities insured through the CNA/HPSO program. All reported pharmacist an ...
... Over the 10-year period included in the study, there were 1,409 reported medication-related incidents, adverse patient outcomes and actual claims against pharmacists, pharmacy technicians, other pharmacy personnel and pharmacy entities insured through the CNA/HPSO program. All reported pharmacist an ...
Opioid Handout - Oral Surgery Albuquerque NM
... impaired control over drug use, compulsive use, continued use despite harm and craving or a combination of these. ...
... impaired control over drug use, compulsive use, continued use despite harm and craving or a combination of these. ...
Tamsulosin and dry mouth Introduction Reports
... seven days. This is in accordance with the proposed mechanism. Of the six cases three had a positive dechallenge and one patient continued the medication and did not recover. One patient had a positive rechallenge. Various studies report dry mouth as the adverse reaction most frequently seen in pati ...
... seven days. This is in accordance with the proposed mechanism. Of the six cases three had a positive dechallenge and one patient continued the medication and did not recover. One patient had a positive rechallenge. Various studies report dry mouth as the adverse reaction most frequently seen in pati ...
Thalidomide and its Analogs: A Potential Immunomodulatory
... 3-tetrafluorophthalimido-3-(3,4-dimethoxyphenyl)propanoate; PEMN, 3-phthalimido-3-(3-ethoxy, 4-methoxyphenyl)-propanitrile (Muller et al., 1996; Muller et al., 1998). Currently, apremilast (CC-10004) is perhaps the most promising drug of this family (Man et al., 2009) (Figure 2). Concerning the mech ...
... 3-tetrafluorophthalimido-3-(3,4-dimethoxyphenyl)propanoate; PEMN, 3-phthalimido-3-(3-ethoxy, 4-methoxyphenyl)-propanitrile (Muller et al., 1996; Muller et al., 1998). Currently, apremilast (CC-10004) is perhaps the most promising drug of this family (Man et al., 2009) (Figure 2). Concerning the mech ...
Product Information: Taladafil
... men with erectile dysfunction (ED). In clinical studies assessing patients’ ability to engage in successful and satisfying sexual activity, tadalafil demonstrated highly statistically significant improvement compared to placebo. Additionally, partners of patients on tadalafil had statistically signi ...
... men with erectile dysfunction (ED). In clinical studies assessing patients’ ability to engage in successful and satisfying sexual activity, tadalafil demonstrated highly statistically significant improvement compared to placebo. Additionally, partners of patients on tadalafil had statistically signi ...
product monograph
... terfenadine, interaction studies have been performed. In one study, 6 healthy volunteers received terfenadine 60 mg BID for 15 days. Fluconazole 200 mg was administered daily from days 9 through 15. Fluconazole did not affect terfenadine plasma concentrations. Terfenadine acid metabolite AUC increas ...
... terfenadine, interaction studies have been performed. In one study, 6 healthy volunteers received terfenadine 60 mg BID for 15 days. Fluconazole 200 mg was administered daily from days 9 through 15. Fluconazole did not affect terfenadine plasma concentrations. Terfenadine acid metabolite AUC increas ...
Diabetes Mellitus (DM) PHCL 442
... Compensatory insulin doses • Usually for each 30-50 mg/dl elevation above the target level 1-2 units of supplemental insulin is required • To be more accurate must determine the supplemental dose of insulin by using the sensitivity factor • Sensitivity factor is determined by using the 1500 or 1800 ...
... Compensatory insulin doses • Usually for each 30-50 mg/dl elevation above the target level 1-2 units of supplemental insulin is required • To be more accurate must determine the supplemental dose of insulin by using the sensitivity factor • Sensitivity factor is determined by using the 1500 or 1800 ...
Product Information for sofosbuvir
... NS5B-associated resistance substitution S282T was not detected in any of these patients by deep sequencing or population sequencing. No other NS5B substitutions were identified to be associated with resistance to sofosbuvir by deep sequencing and phenotypic analyses. Effect of Baseline HCV Polymorph ...
... NS5B-associated resistance substitution S282T was not detected in any of these patients by deep sequencing or population sequencing. No other NS5B substitutions were identified to be associated with resistance to sofosbuvir by deep sequencing and phenotypic analyses. Effect of Baseline HCV Polymorph ...